Biosplice Therapeutics Logo

Biosplice Therapeutics

Life Science

Biotechnology

Health Care

Go back

Ownership

Private

Valuation

$12B

Total Funding

778M

Employees

51-100

About

Biosplice Therapeutics

Medical research and development for tissue-level regeneration

Linkedin Icon/ Link to linkedin profile

Instagram Icon/ Link to instragram profile
Facebook logo icon/ Link to facebook profile
Twitter logo icon/ link to twitter account

More about

Biosplice Therapeutics

Biosplice Therapeutics is in the medical research and development for tissue-level regeneration. With their platform's origins in small molecule-based Wnt pathway modulation, they develop therapeutics to address a range of degenerative diseases, regenerative medicine, and oncology.Samumed adopted a fresh operating philosophy from thebeginning — one based on a goal of building a broad technology platform aimed at modulating regenerative pathways to improve patient health.

Notable Investors

Vickers-Venture-Partners
IKEA-GreenTech
aMoo

Status:

Active

Notable Investors of

Biosplice Therapeutics

No items found.
Go back